Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,167,370
+$773,919 QoQ
Shares Held
1,807
+19.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#2,422
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261248 Management, LLC holds $5,339,017 across 8 Drug Manufacturers - General names. LLY ranks #1 (40.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,807 | $2,167,370 | |
| 2 | ABBV |
AbbVie Inc.
|
4,902 | $1,233,539 | |
| 3 | AMGN |
Amgen Inc
|
2,566 | $929,199 | |
| 4 | AZN |
Astrazeneca PLC
|
2,976 | $564,309 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,910 | $245,435 | |
| 6 | JNJ |
Johnson & Johnson
|
346 | $87,873 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
444 | $56,094 | |
| 8 | GSK |
GSK plc
|
1,053 | $55,198 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,167,370 | 1,807 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,393,451 | 1,515 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,628,140 | 1,515 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,155,945 | 1,515 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,523,201 | 1,954 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $1,594,006 | 1,930 | Shares | Sole | 2025-06-09 | |
| 2024-12-31 | $1,506,172 | 1,951 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||